Internal Medicine, Clinical Cardiatric Electrophysiology · Wichita, KS
NPI
1689890121
Since 2007
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3535 N Webb Rd
Wichita, KS, 67226
Phone (316) 686-5300
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
16,902 services
Medicare patients, 2024
1,917
Average age 75
Drug cost, 2024
$2.4M
11,620 prescriptions
Company payments, 2025
$1,669
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ghiyath Al-Tabbal was code 93000 (electrocardiogram), 2,811 times for 1,486 patients. In total Ghiyath Al-Tabbal billed 16,902 services in 98 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 2,811 | 1,486 | $9.03 | $25K |
| 99214 Office E&M - Established | Office | 2,764 | 1,348 | $84.29 | $233K |
| 93296 External Electrocardiographic Monitoring | Office | 1,482 | 462 | $14.72 | $22K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,449 | 358 | $5.46 | $7,912 |
| 93294 External Electrocardiographic Monitoring | Office | 1,180 | 370 | $21.16 | $25K |
| 93280 External Electrocardiographic Monitoring | Office | 741 | 350 | $52.04 | $39K |
| 93306 Echocardiography (TTE/TEE) | Office | 683 | 633 | $130.05 | $89K |
| 99213 Office E&M - Established | Office | 567 | 464 | $57.91 | $33K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 464 | 231 | $323.46 | $150K |
| 93015 Electrocardiogram | Office | 423 | 418 | $46.45 | $20K |
| 93010 Electrocardiogram | Office | 406 | 313 | $5.38 | $2,184 |
| 93295 External Electrocardiographic Monitoring | Office | 315 | 100 | $25.79 | $8,125 |
| 78431 Myocardial Perfusion Scan | Office | 301 | 300 | $1,678.76 | $505K |
| 78434 Myocardial Perfusion Scan | Office | 301 | 300 | $124.89 | $38K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 237 | 117 | $84.80 | $20K |
By year: 2022 $905K for 14,224 services; 2023 $1.2M for 17,699 services; 2024 $1.5M for 16,902 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 147 | 15 | $4.20 | $617 |
Medicare prescription drug claims, 2024
In 2024, the drug Ghiyath Al-Tabbal prescribed most often to Medicare patients was Flecainide Acetate, with 1,226 prescriptions and refills. In total Ghiyath Al-Tabbal wrote 11,620 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Flecainide Acetate Generic | 1,226 | 2,702 | 299 | $42K |
| Eliquis Apixaban | 921 | 1,582 | 193 | $909K |
| Losartan Potassium Generic | 668 | 1,540 | 175 | $4,270 |
| Metoprolol Tartrate Generic | 654 | 1,525 | 187 | $2,811 |
| Entresto Sacubitril/Valsartan | 654 | 970 | 129 | $634K |
| Furosemide Generic | 528 | 1,175 | 158 | $2,070 |
| Spironolactone Generic | 496 | 877 | 121 | $2,421 |
| Sotalol Sotalol Hcl | 475 | 1,117 | 132 | $7,460 |
| Carvedilol Generic | 442 | 1,014 | 109 | $2,409 |
| Clopidogrel Clopidogrel Bisulfate | 427 | 968 | 102 | $3,438 |
| Amlodipine Besylate Generic | 420 | 937 | 111 | $1,914 |
| Atorvastatin Calcium Generic | 388 | 1,036 | 118 | $2,239 |
| Jardiance Empagliflozin | 334 | 429 | 74 | $243K |
| Amiodarone Hcl Generic | 332 | 749 | 97 | $5,664 |
| Metoprolol Succinate Generic | 329 | 749 | 83 | $2,974 |
Brand drugs: 2,551 claims; generic drugs: 9,069 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ghiyath Al-Tabbal $1,669 ($1,669 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbott Laboratories with $589.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 3 | $589 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $274 |
| Medtronic, Inc. MDT | 4 | $185 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $179 |
| Kestra Medical Technology Services, Inc. | 2 | $154 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $84.71 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $40.44 |
| Pfizer Inc. PFE | 2 | $36.96 |
| Novo Nordisk Inc NVO | 2 | $35.78 |
| CVRx, Inc. CVRX | 1 | $20.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.